ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,275Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 80

$807K Total Retail Price of All Prescriptions

Rank: 5 out of 80

524 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,041 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 37%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $87 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LOSARTAN POTASSIUM 1,016 1,000 1 1
SIMVASTATIN 654 633 2 3
FELODIPINE ER 590 581 10 3 21
PRAVASTATIN SODIUM 584 583 4 13
HYDROCHLOROTHIAZIDE 571 557 5 16
ATORVASTATIN CALCIUM 489 488 6 5
SYNTHROID 362 362 7 35
METFORMIN HCL 352 349 8 8
LISINOPRIL 279 278 9 4
ATENOLOL 257 251 10 29
FUROSEMIDE 251 248 11 10
EVISTA 242 236 12 18
RAMIPRIL 222 215 13 132
JANUVIA 218 216 14 23
OMEPRAZOLE 218 213 14 9
LEVOTHYROXINE SODIUM 218 218 14 6
ALLOPURINOL 167 163 17 14
DONEPEZIL HCL 156 156 18 32
FENOFIBRATE 151 151 19 73
POTASSIUM CHLORIDE 150 147 20 38
ALENDRONATE SODIUM 130 130 21 12
GLIMEPIRIDE 119 119 22 34
FLOVENT HFA 119 114 22 150
METOPROLOL SUCCINATE 118 118 24 11
AZITHROMYCIN 115 113 25 56
DILTIAZEM 24HR ER 111 105 26 99
TAMSULOSIN HCL 106 106 27 47
TERAZOSIN HCL 104 104 28 95
AVAPRO 101 101 29 208
AMLODIPINE BESYLATE 99 98 30 2
LANTUS SOLOSTAR 89 87 31 39
PEN NEEDLE 88 88 32 50
LIPITOR 88 88 32 67
ZETIA 87 84 34 221
RANITIDINE HCL 86 84 35 40
DIGOXIN 73 73 36 48
PROMETHAZINE-CODEINE 69 65 R 37 140
SPIRIVA 69 69 37 92
LEVEMIR FLEXPEN 67 65 39 131
CELEBREX 67 65 39 25
PREDNISONE 65 62 41 15
IRBESARTAN 65 65 41 252
METOPROLOL TARTRATE 65 65 41 20
CITALOPRAM HBR 64 62 44 66
ADVAIR DISKUS 62 60 45 72
FLUTICASONE PROPIONATE 60 59 46 82
CLOPIDOGREL 60 60 46 36
METFORMIN HCL ER 59 46 48 41
DIOVAN 58 58 49 17
GLIPIZIDE ER 57 57 50 42
CRESTOR 55 55 51 31
VITAMIN D2 54 54 52 139
VERAPAMIL ER 52 51 53 147
TRAZODONE HCL 52 52 53 91
MECLIZINE HCL 51 49 55 93
ZOLPIDEM TARTRATE 51 49 55 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.